A large-scale clinical study to investigate the secondary preventive effect of strict antihypertensive therapy in patients with a previous history of stroke.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 16 Dec 2016
At a glance
- Drugs Amlodipine (Primary) ; Losartan (Primary) ; Losartan/hydrochlorothiazide (Primary) ; Spironolactone (Primary)
- Indications Essential hypertension; Stroke
- Focus Therapeutic Use
- Acronyms RESPECTS
- Sponsors BIOMEDIS International
- 15 Dec 2016 Status changed from recruiting to active, no longer recruiting.
- 20 Dec 2010 Actual initiation date (Oct 2010) added as reported by ClinicalTrials.gov.
- 20 Dec 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.